N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide

C86H85BrCl2FN19O3 — CID 157373420

About N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide

N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide (PubChem CID 157373420) has the molecular formula C86H85BrCl2FN19O3 and a molecular weight of 1602.56 g/mol. Its IUPAC name is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide.

Molecular Properties

• Compound Name: N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide
• PubChem CID: 157373420
• Molecular Formula: C86H85BrCl2FN19O3
• Molecular Weight: 1602.56 g/mol
• Exact Mass: 1599.56
• IUPAC Name: N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide
• SMILES: C[C@H](NC(=O)C1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn23)CC1)c1ccccc1.Nc1nccn2c(C3CCC(CNC(=O)Cc4cc(F)c(Cl)nc4Cl)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC(=O)Cc4cccc(Br)c4)CC3)nc(-c3cc4ccccc4[nH]3)c12
• InChI: InChI=1S/C29H29BrN6O.C29H30N6O.C28H26Cl2FN7O/c30-22-6-3-4-19(14-22)15-25(37)33-17-18-8-10-20(11-9-18)29-35-26(27-28(31)32-12-13-36(27)29)24-16-21-5-1-2-7-23(21)34-24;1-18(19-7-3-2-4-8-19)32-29(36)21-13-11-20(12-14-21)28-34-25(26-27(30)31-15-16-35(26)28)24-17-22-9-5-6-10-23(22)33-24;29-25-18(11-19(31)26(30)37-25)13-22(39)34-14-15-5-7-16(8-6-15)28-36-23(24-27(32)33-9-10-38(24)28)21-12-17-3-1-2-4-20(17)35-21/h1-7,12-14,16,18,20,34H,8-11,15,17H2,(H2,31,32)(H,33,37);2-10,15-18,20-21,33H,11-14H2,1H3,(H2,30,31)(H,32,36);1-4,9-12,15-16,35H,5-8,13-14H2,(H2,32,33)(H,34,39)/t;18-,20?,21?;/m.0./s1
• InChIKey: BKAMNUJBPIWWJS-CMKSKRFLSA-N
• XLogP: 17.40
• TPSA: 316.19 Ų
• H-Bond Donors: 9
• H-Bond Acceptors: 16
• Rotatable Bonds: 17
• Heavy Atoms: 112
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1602.56
LogP ≤ 5	17.40
H-Bond Donors ≤ 5	9
H-Bond Acceptors ≤ 10	16

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide?

The IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide (CID 157373420) is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide.

What is the SMILES notation for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide?

The canonical SMILES for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide is C[C@H](NC(=O)C1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn23)CC1)c1ccccc1.Nc1nccn2c(C3CCC(CNC(=O)Cc4cc(F)c(Cl)nc4Cl)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC(CNC(=O)Cc4cccc(Br)c4)CC3)nc(-c3cc4ccccc4[nH]3)c12.

What is the InChIKey of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide?

The InChIKey is BKAMNUJBPIWWJS-CMKSKRFLSA-N. The full InChI is InChI=1S/C29H29BrN6O.C29H30N6O.C28H26Cl2FN7O/c30-22-6-3-4-19(14-22)15-25(37)33-17-18-8-10-20(11-9-18)29-35-26(27-28(31)32-12-13-36(27)29)24-16-21-5-1-2-7-23(21)34-24;1-18(19-7-3-2-4-8-19)32-29(36)21-13-11-20(12-14-21)28-34-25(26-27(30)31-15-16-35(26)28)24-17-22-9-5-6-10-23(22)33-24;29-25-18(11-19(31)26(30)37-25)13-22(39)34-14-15-5-7-16(8-6-15)28-36-23(24-27(32)33-9-10-38(24)28)21-12-17-3-1-2-4-20(17)35-21/h1-7,12-14,16,18,20,34H,8-11,15,17H2,(H2,31,32)(H,33,37);2-10,15-18,20-21,33H,11-14H2,1H3,(H2,30,31)(H,32,36);1-4,9-12,15-16,35H,5-8,13-14H2,(H2,32,33)(H,34,39)/t;18-,20?,21?;/m.0./s1.

What are the key properties of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide?

N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide has a molecular weight of 1602.56 g/mol, XLogP of 17.40, 17 rotatable bonds, 9 hydrogen bond donors, and 16 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(3-bromophenyl)acetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-(2,6-dichloro-5-fluoro-3-pyridinyl)acetamide;4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-N-[(1S)-1-phenylethyl]cyclohexane-1-carboxamide is sourced from PubChem (CID 157373420), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).